Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshimasa Inoue

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Oncology Letters|September 12, 2012
Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancerYoshimasa Inoue, Hozumi Matsumoto, Shunsuke Yamada, et al.
Human Psychopharmacology|June 30, 2012
Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patientsYutaro Suzuki, Naoki Fukui, Nobuto Tsuneyama, et al.
Oncology Letters|September 12, 2012
ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancerYoshimasa Inoue, Hozumi Matsumoto, Shunsuke Yamada, et al.
Journal of Clinical Psychopharmacology|May 16, 2008
Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depressionYutaro Suzuki, Naoki Fukui, Kazushi Sawamura, et al.
European Journal of Clinical Pharmacology|April 17, 2003
Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated allelesYutaro Suzuki, Toshiki Shioiri, Tatsuyuki Muratake, et al.
Journal of Clinical Psychopharmacology|December 17, 2016
Sex Differences in the Effect of Atomoxetine on the QT Interval in Adult Patients With Attention-Deficit Hyperactivity DisorderYutaro Suzuki, Misuzu Tajiri, Atsunori Sugimoto, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 6, 2010
The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patientsYutaro Suzuki, Kazushi Sawamura, Shin Ono, et al.
Human Psychopharmacology|June 4, 2011
Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorderNorio Yasui-Furukori, Shoko Tsuchimine, Taku Nakagami, et al.
European Journal of Clinical Pharmacology|June 21, 2011
Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorderShin Ishiguro, Takashi Watanabe, Mikito Ueda, et al.
European Journal of Clinical Pharmacology|March 5, 2009
Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorderYoshinori Saeki, Takashi Watanabe, Mikito Ueda, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Oncology Letters|September 12, 2012
Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancerYoshimasa Inoue, Hozumi Matsumoto, Shunsuke Yamada, et al.
Human Psychopharmacology|June 30, 2012
Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patientsYutaro Suzuki, Naoki Fukui, Nobuto Tsuneyama, et al.
Oncology Letters|September 12, 2012
ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancerYoshimasa Inoue, Hozumi Matsumoto, Shunsuke Yamada, et al.
Journal of Clinical Psychopharmacology|May 16, 2008
Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depressionYutaro Suzuki, Naoki Fukui, Kazushi Sawamura, et al.
European Journal of Clinical Pharmacology|April 17, 2003
Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated allelesYutaro Suzuki, Toshiki Shioiri, Tatsuyuki Muratake, et al.
Journal of Clinical Psychopharmacology|December 17, 2016
Sex Differences in the Effect of Atomoxetine on the QT Interval in Adult Patients With Attention-Deficit Hyperactivity DisorderYutaro Suzuki, Misuzu Tajiri, Atsunori Sugimoto, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 6, 2010
The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patientsYutaro Suzuki, Kazushi Sawamura, Shin Ono, et al.
Human Psychopharmacology|June 4, 2011
Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorderNorio Yasui-Furukori, Shoko Tsuchimine, Taku Nakagami, et al.
European Journal of Clinical Pharmacology|June 21, 2011
Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorderShin Ishiguro, Takashi Watanabe, Mikito Ueda, et al.
European Journal of Clinical Pharmacology|March 5, 2009
Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorderYoshinori Saeki, Takashi Watanabe, Mikito Ueda, et al.
Pageof 10